💬In plain words
What the trial is, and whether it could suit you
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
1. Chronic post surgical hypoparathyroidism diagnosed \> 1 year ago
2. Age ≥ 18 years
3. Require treatment with active vitamin D ≥ 1 µg/day
4. Ionized plasma calcium between 1.15-1.25 mmol/L
5. 25(OH)D vitamin ≥ 50 nmol/L
6. Plasma magnesium \> 0.65 mmol/L
7. Able to read and understand Danish
8. Willing and able to sign the informed consent form
Exclusion Criteria:
1. Estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73 m3
2. Active cancer or former (except thyroid and basal cell skin) cancer treatment \< 1 year ago
3. Pregnancy, pregnancy plans, or breastfeeding \< 1 year ago
4. Abnormal arterial pressure at time of screening defined as symptomatic hypotension or systolic blood pressure \< 100 mmHg
5. Plasma potassium \< 3.5 mmol/L
6. Any current disease that might affect the calcium metabolism such as but not limited to:
1. Recent prolonged immobility
2. Untreated diabetes (HbA1c \> 53 mmol/mol)
3. Severe liver disease or hepatic encephalopathy
4. Untreated thyroid disease
7. Current disease that might affect gastrointestinal absorption
8. Use of medications such as lithium or diuretics within 4 weeks prior to start of treatment
9. Known allergy or sensitivity to Indapamide, its excipients or sulfonamides
10. Known galactosemia, lactase deficiency, or glucose-galactose malabsorption
💊
What it tests
- Indapamide 1.5 MG SR
- Placebo
Department of Endocrinology and Internal Medicine
Aarhus, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.